Moleculin Biotech, Inc. (MBRX) vs MetaVia Inc. (MTVA)

Moleculin Biotech, Inc. and MetaVia Inc. are both Biotechnology companies. Moleculin Biotech, Inc. and MetaVia Inc. are of similar size ($11.2M and $10.9M). MetaVia Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.1×. Across the 9 metrics below, MetaVia Inc. leads on 5 and Moleculin Biotech, Inc. on 4.

Valuation

Metric MBRX MTVA Biotechnology median
P/E 0.05 n/m 7.88
P/S n/m n/m 11.47
P/B 0.29 1.44 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.11 n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield 1,870.40% (135.29%) (28.84%)
Free cash flow yield (746.71%) (160.83%) (23.03%)

Profitability

Metric MBRX MTVA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,471.05%) (175.68%) (57.72%)
Return on assets (152.41%) (91.06%) (49.22%)
Return on invested capital (417.27%) 0.00% 0.00%

Growth

Metric MBRX MTVA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 82.01% 81.23% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBRX MTVA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.94 2.06 4.73
Net debt to EBITDA 0.35 0.75 0.96

Dividend

Metric MBRX MTVA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric MBRX MTVA Biotechnology median
Market cap 11.17m 10.94m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack